The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.

The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma containing seven evidence-based recommendations.

Apogee Therapeutics reports early trial data showing its asthma drug APG777 sharply reduced a key inflammation marker for up ...

Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 ...

Perioperative hypersensitivity rates vary by sex, with POH occurring more often in female adults and male pediatric patients.

Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

A new study undertaken by the Medical Research Institute of New Zealand (MRINZ) shows that adults with asthma can safely simplify their treatment, reduce overall steroid exposure and improve asthma ...

JAMA Network Open published a recent article, “Tenant Reports of In-Home Asthma Triggers and Adult Emergency Department Use,” examining the association between tenant-reported residential asthma ...

The roughly 28 million Americans living with asthma are familiar with the challenges of inflammation and narrowing of the airways that affects how the lungs are supplied with air. That’s not including ...

Researchers found significant differences in genes potentially linked to adult-onset asthma and childhood-onset asthma, with little overlap between the two. Significant differences were discovered in ...